Navigating Critical Illness Claims
How Different Insurers Respond When Medical Reports Conflict
Case Overview
This case illustrates how different corporate philosophies lead to vastly different outcomes. When faced with ambiguous medical evidence, the approach an insurer takes—whether customer-centric or strictly technical—can make all the difference in a client's time of need.
The Diagnosis
Our client received a cervical cancer diagnosis—a condition affecting hundreds of thousands globally each year. While the news was naturally concerning, she maintained hope in modern medical treatment and the expertise of her healthcare team.
Initial Medical Assessment
The medical team conducted an in-vivo cell extraction at a private hospital. The results indicated aggressive cancer cells, suggesting a more serious form of the disease. Based on this assessment, her physicians recommended surgical intervention to remove the affected tissue.
Post-Surgery Findings
The surgery was successful, providing initial relief. However, a subsequent cell extraction at a public hospital revealed surprising results—no signs of aggressive cancer cells. This contradictory finding suggested the initial assessment may have been inaccurate, raising questions about the necessity of the procedure she had undergone.
The Insurance Challenge
The conflicting medical reports created a complex insurance situation. Both her critical illness policies—one with AIA and one with another major insurer—required medical evidence of aggressive cancer for claim approval. With two contradictory reports, the outcome would depend entirely on each company's approach to such ambiguous situations.
Contrasting Responses
Despite being a customer of the other insurer for over two decades compared to only a few years with AIA, the results were unexpected. AIA approved the claim, while the long-standing insurer declined it.
Understanding the Difference
The difference came down to corporate philosophy. The declining insurer relied solely on the second report showing no aggressive cells. AIA, however, took a customer-centric approach: if any valid medical report indicated aggressive cancer cells, the claim would be honoured. This reflects AIA's commitment to serving and protecting clients rather than using policy technicalities to deny legitimate claims.
The Outcome
- AIA approved the claim based on customer-first principles
- Client received full financial support during her treatment
- The case reinforced trust in AIA's commitment to client protection
- Demonstrated that corporate philosophy directly impacts claim outcomes
Key Learnings
- A customer-centric approach is more valuable than relationship tenure
- Transparent claim policies build stronger client trust
- Corporate philosophy directly influences customer experience
- Client protection should take priority over policy technicalities
Case Details
Client
Cancer Patient
Industry
Healthcare & Insurance
Duration
6 months
Services
Critical Illness Insurance Claims